Dolby Laboratories (DLB) Projected to Post Quarterly Earnings on Wednesday

Dolby Laboratories (NYSE:DLB - Get Free Report) is expected to release its earnings data after the market closes on Wednesday, January 29th. Analysts expect Dolby Laboratories to post earnings of $1.07 per share and revenue of $346,145.33 billion for the quarter. Persons that wish to register for the company's earnings conference call can do so using this link.

Dolby Laboratories Stock Performance

Shares of DLB stock traded down $0.47 on Wednesday, hitting $81.01. The company's stock had a trading volume of 450,395 shares, compared to its average volume of 456,271. Dolby Laboratories has a fifty-two week low of $66.35 and a fifty-two week high of $86.37. The stock's 50 day moving average is $78.48 and its 200-day moving average is $75.61. The company has a market capitalization of $7.73 billion, a PE ratio of 29.89 and a beta of 0.98.

Dolby Laboratories Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 10th. Stockholders of record on Tuesday, December 3rd were issued a dividend of $0.33 per share. This is a positive change from Dolby Laboratories's previous quarterly dividend of $0.30. This represents a $1.32 annualized dividend and a dividend yield of 1.63%. The ex-dividend date of this dividend was Tuesday, December 3rd. Dolby Laboratories's dividend payout ratio is 48.71%.

Insider Transactions at Dolby Laboratories

In other news, Director Peter C. Gotcher sold 6,079 shares of the firm's stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $78.96, for a total value of $479,997.84. Following the completion of the sale, the director now directly owns 37,593 shares in the company, valued at $2,968,343.28. This trade represents a 13.92 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, SVP John D. Couling sold 50,000 shares of the business's stock in a transaction that occurred on Friday, November 22nd. The shares were sold at an average price of $80.04, for a total value of $4,002,000.00. Following the sale, the senior vice president now owns 106,806 shares of the company's stock, valued at approximately $8,548,752.24. This represents a 31.89 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 135,917 shares of company stock worth $10,877,739 over the last three months. 38.39% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

DLB has been the subject of several research analyst reports. Rosenblatt Securities boosted their price objective on shares of Dolby Laboratories from $98.00 to $100.00 and gave the company a "buy" rating in a research report on Wednesday, November 20th. Barrington Research reissued an "outperform" rating and set a $100.00 price target on shares of Dolby Laboratories in a report on Wednesday, November 20th. Finally, StockNews.com raised Dolby Laboratories from a "buy" rating to a "strong-buy" rating in a research note on Wednesday, December 4th.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.